Download pdf - TMV MRI SI - pdfs.semanticscholar.org · mg/ml, (2) 0.5 mg/ml, (3) 0.25 mg/ml, (4) 0.125 mg/ml, and iGd-SNP at (5) 2x dilution and (6) 4x dilution. Supporting Figure 7 Summary comparing

Transcript
Page 1: TMV MRI SI - pdfs.semanticscholar.org · mg/ml, (2) 0.5 mg/ml, (3) 0.25 mg/ml, (4) 0.125 mg/ml, and iGd-SNP at (5) 2x dilution and (6) 4x dilution. Supporting Figure 7 Summary comparing

Page 1 of 6

Supporting Information

Tobacco mosaic virus rods and spheres as supramolecular

high-relaxivity MRI contrast agents

Michael A. Bruckman1, Stephen Hern1, Kai Jiang1, Chris Flask1,2, Xin Yu1,2, Nicole F.

Steinmetz1,2,3*

Department of 1Biomedical Engineering, 2Radiology, 3Materials Science and Engineering,

Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106, USA.

* Corresponding author: Prof. Nicole F. Steinmetz, Department of Biomedical Engineering,

Radiology, Materials Science and Engineering, Case Western Reserve University School of

Medicine, 10900 Euclid Avenue, Cleveland, OH 44106, USA, phone: 216-368-5590, email:

[email protected]

Electronic Supplementary Material (ESI) for Journal of Materials Chemistry BThis journal is © The Royal Society of Chemistry 2013

Page 2: TMV MRI SI - pdfs.semanticscholar.org · mg/ml, (2) 0.5 mg/ml, (3) 0.25 mg/ml, (4) 0.125 mg/ml, and iGd-SNP at (5) 2x dilution and (6) 4x dilution. Supporting Figure 7 Summary comparing

Page 2 of 6

Supporting Figure 1 TEM and SEC images of eAlk-TMV, iAlk-TMV and eGd-TMV.

Electronic Supplementary Material (ESI) for Journal of Materials Chemistry BThis journal is © The Royal Society of Chemistry 2013

Page 3: TMV MRI SI - pdfs.semanticscholar.org · mg/ml, (2) 0.5 mg/ml, (3) 0.25 mg/ml, (4) 0.125 mg/ml, and iGd-SNP at (5) 2x dilution and (6) 4x dilution. Supporting Figure 7 Summary comparing

Page 3 of 6

Supporting Figure 2 MALDI-TOF MS of Native-TMV, eAlk-TMV and iAlk-TMV.

Electronic Supplementary Material (ESI) for Journal of Materials Chemistry BThis journal is © The Royal Society of Chemistry 2013

Page 4: TMV MRI SI - pdfs.semanticscholar.org · mg/ml, (2) 0.5 mg/ml, (3) 0.25 mg/ml, (4) 0.125 mg/ml, and iGd-SNP at (5) 2x dilution and (6) 4x dilution. Supporting Figure 7 Summary comparing

Page 4 of 6

Supporting Figure 3 Before (left) and after (right) images of sucrose gradient density

purifications of (from left to right) eAlk-TMV, eGd-TMV, iAlk-TMV, and iGd-TMV.

Supporting Figure 4 Dynamic light scattering data of iGd-SNPs formed from iGd-TMV

used in this paper.

Electronic Supplementary Material (ESI) for Journal of Materials Chemistry BThis journal is © The Royal Society of Chemistry 2013

Page 5: TMV MRI SI - pdfs.semanticscholar.org · mg/ml, (2) 0.5 mg/ml, (3) 0.25 mg/ml, (4) 0.125 mg/ml, and iGd-SNP at (5) 2x dilution and (6) 4x dilution. Supporting Figure 7 Summary comparing

Page 5 of 6

Supporting Figure 5 NanoDSC analysis of native-TMV and iAlk-TMV showing an increase

in stability of iAlk-TMV over native-TMV.

Supporting Figure 6 SDS-PAGE of denatured TMV samples and subsequent lane analysis to

determine the protein concentration of iGd-SNPs. Lane assignments: Native TMV at (1) 1.0

Electronic Supplementary Material (ESI) for Journal of Materials Chemistry BThis journal is © The Royal Society of Chemistry 2013

Page 6: TMV MRI SI - pdfs.semanticscholar.org · mg/ml, (2) 0.5 mg/ml, (3) 0.25 mg/ml, (4) 0.125 mg/ml, and iGd-SNP at (5) 2x dilution and (6) 4x dilution. Supporting Figure 7 Summary comparing

Page 6 of 6

mg/ml, (2) 0.5 mg/ml, (3) 0.25 mg/ml, (4) 0.125 mg/ml, and iGd-SNP at (5) 2x dilution and

(6) 4x dilution.

Supporting Figure 7 Summary comparing relaxivity per volume (R1/V) of viral nanoparticle

MRI contrast agents. References match paper order.

Electronic Supplementary Material (ESI) for Journal of Materials Chemistry BThis journal is © The Royal Society of Chemistry 2013


Recommended

Stanford Health Care Advantage 2019 Abridged …...amoxicillin oral suspension for reconstitution 125 mg/5 ml, 200 mg/5 ml, 250 mg/5 ml, 400 mg/5 ml 1 GC amoxicillin oral tablet 500
Stanford Health Care Advantage 2019 Abridged …...amoxicillin oral suspension for reconstitution 125 mg/5 ml, 200 mg/5 ml, 250 mg/5 ml, 400 mg/5 ml 1 GC amoxicillin oral tablet 500 Documents
Preferred Drug List - Passportpassporthealthplan.com/wp-content/uploads/2014/12/... · KETOROLAC TROMETHAMINE (15 MG/ML VIAL, 30MG/ML(1) VIAL, 30 MG/ML CARTRIDGE, 10 MG TABLET, 30
Preferred Drug List - Passportpassporthealthplan.com/wp-content/uploads/2014/12/... · KETOROLAC TROMETHAMINE (15 MG/ML VIAL, 30MG/ML(1) VIAL, 30 MG/ML CARTRIDGE, 10 MG TABLET, 30 Documents
Erbitux 5 mg/mL Erbitux 5 mg/mL
Erbitux 5 mg/mL Erbitux 5 mg/mL Documents
FOR DEEP INTRAMUSCULAR GLUTEAL INJECTION ONLY. NOT … Recon... · 2016-05-20 · Dose Vial Strength Diluent to Add 150 mg 210 mg 1.3 mL 210 mg 210 mg 1.3 mL 300 mg 300 mg 1.8 mL
FOR DEEP INTRAMUSCULAR GLUTEAL INJECTION ONLY. NOT … Recon... · 2016-05-20 · Dose Vial Strength Diluent to Add 150 mg 210 mg 1.3 mL 210 mg 210 mg 1.3 mL 300 mg 300 mg 1.8 mL Documents
dzumenvis.nic.indzumenvis.nic.in/BAM Bacillus cereus.docx · Web viewPrepare serial dilutions from 10-2 to 10-6 by transferring 10 mL homogenized sample (1:10 dilution) to 90 mL dilution
dzumenvis.nic.indzumenvis.nic.in/BAM Bacillus cereus.docx · Web viewPrepare serial dilutions from 10-2 to 10-6 by transferring 10 mL homogenized sample (1:10 dilution) to 90 mL dilution Documents
Capsules: 150 mg, 300 mg, 600 mg of lithium carbonate (3 ...€¦ · 5.10 Pseudotumor Cerebri ... 150 mg 4 mEq (2.5 mL) 300 mg 8 mEq (5 mL) 600 mg 16 mEq (10 mL) 2.3 Serum Lithium
Capsules: 150 mg, 300 mg, 600 mg of lithium carbonate (3 ...€¦ · 5.10 Pseudotumor Cerebri ... 150 mg 4 mEq (2.5 mL) 300 mg 8 mEq (5 mL) 600 mg 16 mEq (10 mL) 2.3 Serum Lithium Documents
Community-acquired pneumonia: 500 mg as a single daily dose by … · 2017-02-13 · 1.0 mg/mL 500 mL 2.0 mg/mL 250 mL Other intravenous substances, additives, or medications should
Community-acquired pneumonia: 500 mg as a single daily dose by … · 2017-02-13 · 1.0 mg/mL 500 mL 2.0 mg/mL 250 mL Other intravenous substances, additives, or medications should Documents
Haldol - Art 30 - Assessment Report · mg/ml and 10 mg/ml) and injectable solution (5 mg/ml). 2. Scientific discussion 2.1. Introduction Haldol, which contains the active substance
Haldol - Art 30 - Assessment Report · mg/ml and 10 mg/ml) and injectable solution (5 mg/ml). 2. Scientific discussion 2.1. Introduction Haldol, which contains the active substance Documents
Beyond Genetics - PHARMAQO LABS · Injection Steroids 400 mg./ml. 10 ml. vial. 150 mg./ml. 10 ml. vial. 400 mg./ml. 10 ml. vial. 10 ml. vial. Visit our website for more products and
Beyond Genetics - PHARMAQO LABS · Injection Steroids 400 mg./ml. 10 ml. vial. 150 mg./ml. 10 ml. vial. 400 mg./ml. 10 ml. vial. 10 ml. vial. Visit our website for more products and Documents
SINTESIS PROTEIN MIKROBA DAN AKTIVITAS ...sampai terendah yaitu T2 (59,50 mg/ml), T3 (55,58 mg/ml), T4 (47,55 mg/ml), T5 (42,82 mg/ml) dan T1 (31,68 mg/ml). Perbedaan dari masing–masing
SINTESIS PROTEIN MIKROBA DAN AKTIVITAS ...sampai terendah yaitu T2 (59,50 mg/ml), T3 (55,58 mg/ml), T4 (47,55 mg/ml), T5 (42,82 mg/ml) dan T1 (31,68 mg/ml). Perbedaan dari masing–masing Documents
PRODUCT MONOGRAPH...PRODUCT MONOGRAPH Pr CABAZITAXEL FOR INJECTION Manufacturer’s Standard Concentrated Solution 10 mg/mL (45 mg/4.5 mL & 60 mg/6 mL) Antineoplastic Agent L01CD04
PRODUCT MONOGRAPH...PRODUCT MONOGRAPH Pr CABAZITAXEL FOR INJECTION Manufacturer’s Standard Concentrated Solution 10 mg/mL (45 mg/4.5 mL & 60 mg/6 mL) Antineoplastic Agent L01CD04 Documents
Fluconazole 2 mg/ml solution for infusion (fluconazole) · UKPAR Fluconazole 2 mg/ml Solution for Infusion PL 24780/0003 Fluconazole 2 mg/ml solution for infusion (fluconazole) PL
Fluconazole 2 mg/ml solution for infusion (fluconazole) · UKPAR Fluconazole 2 mg/ml Solution for Infusion PL 24780/0003 Fluconazole 2 mg/ml solution for infusion (fluconazole) PL Documents
Symbiotic Human Gut Bacteria with Variable Metabolic ... · 1.0 0.8 0.6 0.4 0.2 0 0 500 1000 1500 2000 2500 3000 8 mg/ml PMOG 1 mg/ml levan 6 mg/ml PMOG 2 mg/ml levan 4 mg/ml PMOG
Symbiotic Human Gut Bacteria with Variable Metabolic ... · 1.0 0.8 0.6 0.4 0.2 0 0 500 1000 1500 2000 2500 3000 8 mg/ml PMOG 1 mg/ml levan 6 mg/ml PMOG 2 mg/ml levan 4 mg/ml PMOG Documents
Fentanyl Decontamination Studies€¦ · Decon mass[mL]) Target mass (mg) Decon volume (mL) Sample pH Dilution Volume(mL) Expected Concentration (mg/mL) 2Observed Concentration (mg/mL)
Fentanyl Decontamination Studies€¦ · Decon mass[mL]) Target mass (mg) Decon volume (mL) Sample pH Dilution Volume(mL) Expected Concentration (mg/mL) 2Observed Concentration (mg/mL) Documents
HETEROGENEOUS SODİUM DEATUNGSTATE ATALYSTS FOR …€¦ · Propranolol b-BLOCKER 361.4 253.3 290.3 363.3 266.3 1.44 mg/mL 0.459 mg/mL 0.615 mg/mL 0.152 mg/mL 0.0794 mg/mL 5.4 5.6
HETEROGENEOUS SODİUM DEATUNGSTATE ATALYSTS FOR …€¦ · Propranolol b-BLOCKER 361.4 253.3 290.3 363.3 266.3 1.44 mg/mL 0.459 mg/mL 0.615 mg/mL 0.152 mg/mL 0.0794 mg/mL 5.4 5.6 Documents
CUSTOMER OFFER...Suggested use: 0.15 ml BalanceOil per kilo body weight BalanceOil, 300 ml 2500 mg PER 12 ML Omega-3 EPA 1300 mg PER 12 ML DHA 700 mg PER 12 ML DPA 150 mg PER 12 ML
CUSTOMER OFFER...Suggested use: 0.15 ml BalanceOil per kilo body weight BalanceOil, 300 ml 2500 mg PER 12 ML Omega-3 EPA 1300 mg PER 12 ML DHA 700 mg PER 12 ML DPA 150 mg PER 12 ML Documents
FARM ANIMALS PRODUCTS€¦ · 100 mg/ml menbutone 25 mg/ml Polymerized silicone 500.000 IU/ml Vitamin A, 75.000 IU/ml Vitamin D3, 50 mg/ml Vitamin E 100 mg/ml Butaphosphan, 0.05 mg/ml
FARM ANIMALS PRODUCTS€¦ · 100 mg/ml menbutone 25 mg/ml Polymerized silicone 500.000 IU/ml Vitamin A, 75.000 IU/ml Vitamin D3, 50 mg/ml Vitamin E 100 mg/ml Butaphosphan, 0.05 mg/ml Documents
EPTIFIBATIDE - Slate Run Pharmaceuticals...EPTIFIBATIDE INJECTION PRODUCT DETAILS • Concentration: Available in 2 mg per mL (20 mg/10 mL) or 0.75 mg per mL (75 mg/100 mL) • Fill
EPTIFIBATIDE - Slate Run Pharmaceuticals...EPTIFIBATIDE INJECTION PRODUCT DETAILS • Concentration: Available in 2 mg per mL (20 mg/10 mL) or 0.75 mg per mL (75 mg/100 mL) • Fill Documents